Cognitive impairment: Classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging;Deterioro cognitivo: Clasificación mediante espectroscopia de resonancia magnética de protón y contribución de la imagen convencional

Radiologia

Volumn 48, Issue 5, 2006, Pages 301-307

  Martinez Bisbal M C ^a,b   Arana, E ^a,b   Marti Bonmati L ^b,c   Martinez Granados B ^a   Celda, B ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL QUIRÓN   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Alzheimer's disease; In vivo spectroscopy; Magnetic resonance; Magnetic resonance image; Mild cognitive impairment; Vascular dementia

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CINGULATE GYRUS; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; RADIODIAGNOSIS; ROC CURVE; TEMPORAL LOBE;

EID: 33750999369     PISSN: 00338338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8338(06)75139-6     Document Type: Article

References (29)

1. Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Molla E, Celda B. Cognitive impairment: classification by 1H magnetic resonance spectroscopy. Eur J Neurol. 2004;11:187-93.
2. 1H MR Spectroscopy. AJNR. 2000;21:621-30.
3. Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease. A 1HMRS study. Neurology. 2000;55:210-7.
4. Chantal S, Labelle M, Bouchard RW, Braun CMJ, Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer Disease. Arch Neurol. 2002;59:955-62.
5. Burns A, Zaudig M. Mild cognitive impairment in older people. Lancet. 2002;360:1963-5.
6. Evans M, Mottram P. Diagnosis of depression in elderly patients. Adv Psychiatr Trends. 2000;6:49-56.
7. Reischies F, Neu P. Comorbidty of mild cognitive disorder and depression- a neuropsychological analysis. Eur Arch Psychiatry Clin Neurosci. 2000;250:186-93.
8. Murata T, Kimura H, Omori M, Kado H, Kosaka H, Iidaka T, et al. MRI white matter hyperintensities, 1H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases. Int J Geriatr Psychiatry. 2001;16:1129-35.
9. Castillo M, Kwock L. Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. Top Magn Reson Imaging. 1999;10:104-13.
10. 1MRS study. J Neurol. 2003;250:22-8.
11. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch Gen Psychiatry. 1999;56:185-92.
12. Jessen F, Block W, Traber F, Keller E, Flacke S, Papassotiropoulos A, et al. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology. 2000;55:684-8.
13. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology. 2001;56:592-8.
14. MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H Magnetic Resonance Spectroscopic Imaging. Arch Neurol. 1996;53:167-74.
15. Frisoni P, Scheltens S, Galluzzi F, Nobili M, Fox NC, Robert PH, et al. Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry. 2003;74:1371-81.
16. Kantarci K, Xu Y, Shiung MM, O'Brien PC, Cha RH, Smith GE, et al. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;14:198-207.
17. Asociación Americana de Psiquiatriá. DSM-IV Manual diagnóstico y estadístico de los trastornos mentales. 1st ed. Barcelona: Masson; 2003.
18. Roman G, Tabemichi T, Erkinjuntti T. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology. 1993;43:250-60.
19. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in «probable» Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55:967-72.
20. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, et al. Java-based graphical user interface for the MRUI quanti tation package. MAGMA; 12:141-52.
21. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc. 2002;8:934-42.
22. Gottfries C. Late life depression. Eur Arch Psychiatry Clin Neurosci. 2001;251:57-61.
23. Wolf H, Jelic V, Gertz H, Nordberg A, Julin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand. 2003;107:52-76.
24. Scahill R, Schott J, Stevens J, Rossor M, Fox N. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci. 2002;99:4703-7.
25. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci. 2001;98:12796-801.
26. Silverstone P, Hanstock C, Rotzinger S. Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy. J Psychiatry Neurosci. 1999;24:222-6.
27. Hamakawa H, Kato T, Murashita J, Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci. 1998;248:53-8.
28. Morris J, Price J. Pathologic correlates of non demented aging, mild cognitive impairment and early-stage Alzheimer's disease. J Mol Neurosci. 2001;17:101-18.
29. Palmer K, Fratiglioni L, Winblad B. What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment. Acta Neurol Scand. 2003;107:14-20.